Ibiglustat

N/A

Report date: 2026/03/18 16:27:25
NME

Base Information

Drug NameIbiglustat
Drug Alias NameVenglustatVenglustat malate - Sanofi GenzymeVenglustat - Sanofi GenzymeVenglustat malateGZ/SAR402671A +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCeramide glucosyltransferase inhibitors
TargetsCeramide glucosyltransferase
Therapy Area/IndicationsGaucher's disease type IIIGaucher's disease type IPolycystic Kidney, Autosomal Dominant +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[35] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesSanofiGenzyme CorpSanofi Synthelabo Hk Ltd +[5] 
Inactive CompaniesSanofi Us Services Inc
Active IndicationsGaucher's disease type IIIGaucher's disease type IGaucher Disease +[4] 
Inactive IndicationsPolycystic Kidney, Autosomal DominantKidney Diseases, CysticTay-Sachs Disease +[5] 

Other Information

ATC CodeN/A
Related LinksN/A